The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Brazilian Journal of Infectious Diseases
(Jan 2021)
EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3 TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS GEMINI
Pedro Cahn,
Juan Sierra Madero,
José Ramón Arribas,
Jörg Sievers,
Choy Man,
Rimgaile Urbaityte,
Mark Underwood,
Jean Andre Van Wyk,
Kimberly Smith,
Roberto Zajdenverg
Affiliations
Pedro Cahn
GlaxoSmithKline (GSK), Brasil
Juan Sierra Madero
GlaxoSmithKline (GSK), Brasil
José Ramón Arribas
GlaxoSmithKline (GSK), Brasil
Jörg Sievers
GlaxoSmithKline (GSK), Brasil
Choy Man
GlaxoSmithKline (GSK), Brasil
Rimgaile Urbaityte
GlaxoSmithKline (GSK), Brasil
Mark Underwood
GlaxoSmithKline (GSK), Brasil
Jean Andre Van Wyk
GlaxoSmithKline (GSK), Brasil
Kimberly Smith
GlaxoSmithKline (GSK), Brasil
Roberto Zajdenverg
GlaxoSmithKline (GSK), Brasil
Journal volume & issue
Vol. 25
p. 101259
Abstract
Read online
No abstracts available.
WeChat QR code
Close